Silvia Steiner
Having joined Osborne Clarke in 2007, there’s little doubt about Silvia’s specialism – she has devoted her entire career to life sciences and healthcare.
Today, Silvia applies that wealth of knowledge to her role. In doing so, she has worked with a wealth of high-profile clients, both nationally and internationally, including a long-term relationship with one of the world leaders in plasma-based products.
An expert in commercial law, Silvia is often called on for her advisory skills in commercial transactions, as well as regulatory issues around clinical trials, R&D activities and market access. In each instance, her approach is collaborative – in a sector which is evolving rapidly, Silvia works in close co-ordination with every client, keeping pace with change as it happens.
During her career Silvia has also gained considerable experience and skill in Corporate Compliance, with a particular focus in anticorruption related matters.
On 1 January 2022 the amendments to the Spanish Consumer Law will enter into force. Such amendments are introduced by...
With technological advances increasing access to patient support programmes, what legal and regulatory issues do pharmaceutical companies need to take...
The transposition period of the Directive (EU) 2019/1937 of 23 October 2019 on the protection of persons who report breaches...
The pandemic, coupled with the significant economic downturn, continues to produce pressures on businesses that could prove to be fertile...
The definition of "foreign official” and clarification of criminal violations of accounting provisions are among the updates in a new...
The Resource Guide to the U.S. Foreign Corrupt Practices Act (the "Resource Guide") was originally released in November 2012. The...
The European telemedicine industry is on the rise as a result of recent legalisation of activities such as remote treatment...